A magnetic resonance approach is presented that enables high-sensitivity, highcontrast molecular imaging by exploiting xenon biosensors. These sensors link xenon atoms to specific biomolecular targets, coupling the high sensitivity of hyperpolarized nuclei with the specificity of biochemical interactions. We demonstrate spatial resolution of a specific target protein in vitro at micromolar concentration, with a readout scheme that reduces the required acquisition time by >3300 fold relative to direct detection. This technique uses the signal of free hyperpolarized xenon to dramatically amplify the sensor signal via chemical exchange saturation transfer (CEST). Because it is ~10,000 times more sensitive than previous CEST methods and other molecular magnetic resonance imaging techniques, it marks a critical step towards the application of xenon biosensors as selective contrast agents in biomedical applications.
Magnetic resonance imaging (MRI) is established as a powerful method for tomography of opaque biological samples (1) . However, its application in molecular imaging (determining the spatial distribution of specific molecules of interest) has been limited due to inherent low sensitivity (2) . Conventional MRI techniques usually detect highly abundant nuclei, such as protons ( 1 H) of water (110 M 1 H concentration) and/or fat to guarantee sufficient signal intensity despite the low thermal polarization. Contrast agents, including some that bind to specific biomolecular targets, have been developed that induce small but detectable changes in these strong signals. However, the required contrast agent concentration is ~0.5 to 2 mM for signal changes based on relaxation enhancements (2) or saturation transfer experiments (3). Application of exogenous 129 Xe circumvents limitations in sensitivity and contrast because Xe nuclei can be hyperpolarized prior to transfer into the system of interest and their nuclear magnetic resonance (NMR) frequencies are extremely sensitive to the molecular environment. Hyperpolarization amplifies the available magnetization by a factor of >10 4 and it is currently used to increase anatomical contrast in MRI for imaging of void spaces such as the lung (4).
Detection of specific biomolecules in a solution environment can be accomplished by xenon biosensors, which trap Xe atoms in molecular cages that have been functionalized to bind the desired target (5, 6) . Xenon biosensors are composed of a cryptophane-A cage (7) , linker, and targeting moiety ( Fig. 1a ), which can be an antibody or ligand that enables detection of a specific analyte. The cage-encapsulated xenon nuclei give rise to a unique signal that differs significantly from that of free Xe. Hence, these compounds act as selective imaging contrast agents for near-zero background MRI that benefit from the high specificity of biochemical targeting (5, 6) . The excellent resolution of free and biosensorbound Xe was used recently to obtain a one-dimensional NMR profile from a beadimmobilized biosensor in a perfusion phantom that delivers Xe saturated water to a test volume inside the NMR probe (8) . This setup mimics in principle Xe delivery to a biosensor-labeled volume of interest as it would be provided by the blood stream in vivo after injection or inhalation. Direct application of the xenon biosensor to molecular imaging has been impaired by the fact that for typical experiments, only ~1% of dissolved Xe is associated with the sensor (9) . A further challenge was shown to lie in the broadening of sensor signal in heterogeneous samples (8, 9) , leading to a significant reduction in signal-to-noise.
Here, we introduce a different approach for obtaining MR images of Xe biosensors that is based on chemical exchange between the biosensor-encapsulated Xe and the easily detectable pool of free Xe (10), thus making optimized use of the available biosensorassociated magnetization. These Xe nuclei fulfill the conditions of slow exchange on the NMR timescale, i.e., the frequency difference of the resonances (Δω) is large compared to the exchange rate (τ ex -1 ) between the two sites: Δω >> τ ex -1 . Such exchange is used for signal amplification by measuring a decrease in the intense free xenon signal after selective saturation of the biosensor-bound xenon. Exchange-mediated depletion of the free xenon signal requires that the exchange rate be fast compared to the longitudinal relaxation time of free xenon (τ ex -1 >> T 1 -1 ) and that the saturation be effective (transition rate W ≥ τ ex -1 ).
With a value of T 1 ≈ 66 s in water (11) at 9.4 T and exchange dynamics characterized by τ ex ≈ 40 ms (10) , Xe nuclei in the sensor cages are ideal for saturation transfer.
The applied technique is similar to chemical exchange saturation transfer, or CEST (12) , which was previously developed for use with proton contrast agents. However, because the method presented here, HYPER-CEST, uses hyperpolarized nuclei with a long relaxation time, nearly the entire sensor-related magnetization depletion is stored in the observed signal
This scheme allows significant sensitivity improvement, which we demonstrate with two-dimensional images that were obtained in a few minutes of a biosensor solution sample with ~5 µM concentration of a recently described biosensor construct (8, 9) that binds via its biotin moiety to avidin-functionalized agarose beads in an aqueous environment. 129 Xe NMR spectra of such bead samples are comprised of three different signals ( Fig. 1a ): free Xe in the bead medium resonates at δ 1 = 193.6 ppm (referred to as "bead signal" in the following), free Xe in pure water at δ 2 = 192.5 ppm, and Xe inside the biosensor cage at δ 3 = 65.4 ppm (chemical shifts are calibrated relative to the Xe gas signal at δ = 0 ppm). Selective presaturation around δ 3 initiates the HYPER-CEST process ( Fig.   1b ) that accumulates selectively depolarized nuclei in a cyclic process ( Fig. 1b ). Because the depolarized magnetization M z = 0 cannot be detected directly, the difference of MRI datasets with on-and off-resonant presaturation allows for sensitive detection of sample regions of dilute biosensor.
Chemical shift imaging (CSI) is an MRI method that preserves the intrinsic frequency information of NMR signals (13) . It uses pulsed magnetic field gradients to generate phase encoded signals in the frequency domain and provides maps of spatially resolved NMR spectra after 2-dimensional Fourier transformation (FT). This method yields selective images for any spectral component. To demonstrate specificity of the biosensor imaging method, agarose beads were embedded in a flow system described previously (8) such that the volume of interest is divided into two compartments ( Fig. 2a ).
Volume 2 contained avidin-agarose beads (9) with biosensor bound at a concentration of 5 µM and volume 1 contained biosensor-free beads. The phantom was attached to an apparatus that provides perfusion with Xe saturated water, as previously described (8) The excellent biosensor specificity is shown in Fig. 2b . A reference spectrum is given for off-resonant 4 s continuous wave (cw) saturation at
Switching the frequency to δ on = δ 1 -Δ = δ 3 causes a significant depletion of the bead signal at δ 1 for 2, whereas the spectrum from volume 1 remains essentially unaffected.
Hence, the Fourier transform of the difference raw data only contains bead signal for areas participating in the saturation transfer as a consequence of biosensor labeling.
The corresponding images given in Fig. 3 illustrate the inherent multimodal contrast of our technique, i.e. imaging contrast provided by both the chemical shift information and the tunable HYPER-CEST effect. The dataset with off-resonant presaturation displays the compartments that contain both types of beads when only the signal intensity at δ 1 is evaluated (Fig. 3a) . This Xe image matches precisely the geometry seen in the conventional 1 H MR image in Fig. 2a . Additional information is given by plotting the signal distribution of the solution dissolved xenon peak, δ 2 . It displays the surrounding outlet tube of the phantom (Fig. 3b) , i.e., a volume that contains the perfusion agent but that does not contain the biosensor or its molecular target. These images show a near-zero background due to the good spectral discrimination of the signal components. On-resonant presaturation depletes the δ 1 signal in compartment 2, leaving the signal in compartment 1 undisturbed (Fig. 3c) . The difference image for δ 1 shown in Fig. 3d decrease of no more than 4 to 12%, even when the concentration of polarized nuclei is to the results reported here, i.e. a signal decrease of 40 to 50%, was observed with CEST using exchangeable sites on macromolecules at 100 µM (14) . However, those results for poly-L-lysine were based on concentrations of 700 mM for the exchangeable sites and 8.7
mM for the polarized nuclei (water at 11.7 T). Hence, the sensitivity gain given by HYPER-CEST provides the same contrast with only 1/140,000 of active sites and 1/4350 of detectable nuclei.
The results presented emphasize the high potential for molecular imaging based on the Xe biosensor in combination with HYPER-CEST. If the same images were acquired using a conventional direct detection methodology, over 870 hrs would be required (see SOM). Therefore this technique marks a critical step towards the application of xenon biosensors as a selective contrast agent in biomedical MRI. Because the specificity of the sensor is determined by the functionality of its targeting agent, we envision that the combination of HYPER-CEST with the xenon biosensor can be used to image any molecular target for which an affinity agent (e.g., ligand, antibody, etc.) is known.
Sensitivity relies predominantly on the signal-to-noise ratio (SNR) of the resonance of free Xe and is independent of the biosensor signal linewidth that previously limited the SNR (8) . Moreover, this technique provides an adjustable contrast that can be switched on and off at-will because the HYPER-CEST effect depends on the saturation power (of course, the signal contrast as given in Fig. 2b also depends on the biosensor concentration; see SOM). At this stage, we can detect a voxel of 22.5µL ≈ (2.8 mm) 3 in a coil volume of ca.
2.8 mL for a biosensor concentration of 5 µM. However, several possibilities for improvement should lead to even further sensitivity enhancement. Using isotopicallyenriched 129 Xe will increase the S/N by a factor of ~4, and optimized polarization procedures (15) can increase the signal by another factor of 15. Hence, these straightforward optimizations decrease the limit of detection by 60-fold to ~85 nM Xe biosensor. This limit can be further decreased by increasing the cage-to-target ratio via chemical means, by designing the probe constructs such that the target molecule binds more than one biosensor (avidin, e.g., has a capacity of 4), or constructing each biosensor from more than one cryptophane cage, for example through dendrimeric amplification (16) . Using these means the minimum concentration of the target structure should reach the low nM to high pM range for optimized in vitro experiments. Hence, application of HYPER-CEST to xenon biosensors represents a new dimension of sensitivity and specificity for molecular imaging. The depletion process generating the image contrast depends on several parameters, including saturation power and time, sensor concentration and ambient temperature. The latter parameter provides another promising approach to even further increase sensitivity because the exchange rate increases significantly when approaching 37°C (10) . Characterization of the saturation dynamics is currently underway and will reveal optimized parameters for future applications.
The technique is also quite promising for biomedical imaging in vivo. A typical surface coil of 20 cm diameter detects a volume of ca. 2.1 L, thus decreasing SNR for a (2.8 mm) 3 voxel by factor 27.2 compared to our setup. This loss is less than 50% of the gain for an optimized system using >45% polarized isotopically enriched 129 Xe. An isotropic resolution of 2 to 3 mm is feasible without signal averaging for a concentration of pure polarized 129 Xe that is ~2 µM in tissue. This minimum value is below that observed for direct injection of Xe-carrying lipid solutions into rat muscle (70 µM) or that for inhalation delivery for brain tissue (8 µM) used in previous studies that demonstrated Xe tissue imaging in vivo (17) . Sensitive molecular imaging of the biosensor is therefore possible as long as the distribution of dissolved xenon can be imaged with sufficient SNR and the biosensor target is not too dilute, because HYPER-CEST is based on the detection of the free Xe resonance, not direct detection of the biosensor resonance.
The HYPER-CEST technique is amenable to any type of MRI image acquisition methodology. We demonstrated CSI here but faster acquisition techniques that incorporate a frequency encoding domain such as FLASH have been successfully used to acquire in vivo Xe tissue images (17) .
The modular set-up of the biosensor (i.e., the nuclei that are detected are not covalently bound to the targeting molecule) allows accumulation of the biosensor in the tissue for minutes to hours prior to delivery of the hyperpolarized xenon nuclei which have much higher diffusivity. In combination with the long spin-lattice relaxation time of Xe, this two-step process optimally preserves the hyperpolarization before signal acquisition.
Biosensor cages that yield distinct xenon frequencies allow for multiplexing to detect simultaneously several different targets (18) . Also the serum-and tissue-specific Xe NMR signals (19, 20) arising after injection of the carrier medium can be used for perfusion studies (see Fig. 3b ) in living tissue, making Xe-CSI a multi-modal imaging technique. 
